newsfilter
← Latest News
GlobeNewswire·

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

LEXINGTON, Mass. and AMSTERDAM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced